According to Aipeng Medical, recently, Shenzhen Pengrui Brain Science & Technology Co., Ltd., a subsidiary of Aipeng Medical, completed the acquisition of attention deficit training and treatment software, further laid out the field of digital therapy, improved the ADHD brain health product system, and accelerated the construction of an innovative model for integrating software and hardware. The acquisition will further enrich Pengrui Brain Science's ADHD product layout and form a collaboration with existing brain-computer related technologies.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.